Adrenergic receptorDistributed in mostsympathetic nervePostganglionic fibreDominatedEffectorcell membraneIts receptors can be divided into three types, namely, β 1 receptor, β 2 receptor and β 3 receptor.β 1 receptor is mainly distributed in myocardium, which can excite heart rate andMyocardial contractilityIncrease;β 2 receptor exists in bronchial and vascular smooth muscle and can be induced by activationbronchiectasia、VasodilationVisceral smooth muscle relaxation;β 3 receptor mainly exists infat cellsYes, it can be excitedLipolysis。These effects can be blocked and antagonized by beta blockers.
Beta blockers can be divided into three categories: ① non selective beta blockers that block both beta 1 and beta 2 receptors, such as propranolol; ②Selective beta blockers have little or no effect on beta 2 receptors, such asBisoprololEtc.; ③Block α 1 and β receptors, such as carvedilol.
βReceptor blockerHigh dose application may occurSerious adverse reactions① Cardiovascular system: it can slow down the heart rate and even cause severe bradycardia and atrioventricular block, mainly seen inSinoatrial nodePatients with impaired atrioventricular node function; ②Metabolic system: some vigilance symptoms of hypoglycemia such as tremor and tachycardia can be masked by the use of non selective beta blockers in patients with type 1 diabetes mellitus; ③Respiratory system: can causeairway resistance Increase, so it is forbidden to use it for asthma or bronchospasm chronic obstructive pulmonary disease; ④Central nervous system: fatigue, headache, sleep disorder, insomniaabnormal sweatingAnd depression; ⑤Drug withdrawal syndrome: after long-term treatment, sudden drug withdrawal may occur, with hypertension, arrhythmia, and worsening angina pectoris.
Disable or use with caution
Beta blockers should not be used or should be used cautiously in the following situations: bronchial spastic asthma, symptomatic hypotension, bradycardia or atrioventricular block of more than second degree type II, heart failure withSignificanceSodium retention requires extensive diuresis, andHemodynamicsUnstable requires intravenous applicationPositive inotropic agentEtc.However, for mostCardiovascular diseasePatients with chronic obstructive pulmonary disease without bronchospasm orPeripheral vascular disease% of patients with cardiovascular disease could still benefit significantly from beta blocker treatment;Diabetes mellitus and intermittent claudication of lower limbs are not absolute contraindications.
Application in hypertension
Beta blockers via antagonismsympathetic nerveThe main antihypertensive mechanism involves reducing cardiac output and improvingBaroreceptorIt can regulate the blood pressure and regulate the blood pressure, and inhibit the renin angiotensin aldosterone system;It can also prevent the cardiotoxic effect of catecholamine by reducing the sympathetic nerve tension.
Beta blocker is one of the initial and long-term antihypertensive drugs for hypertensive patients, which can be used alone or in combination with other antihypertensive drugs.nothingcomplicationEighty five percent of young and middle-aged patients with hypertension may consider the use of beta blockers.Hypertension patients with the following conditions should give priority to the use of beta blockers:RapidityArrhythmia (e.gSinus tachycardia、Atrial fibrillation)、Coronary atherosclerotic heart disease(coronary heart disease, such as angina pectoris and myocardial infarction)chronic heart failure, and increased sympathetic nerve activity, such as anxiety, tension and other mental stress,Perioperative periodPatients with hypertension and high circulatory status such as hyperthyroidism.It is recommended to use β receptor blockers that have no intrinsic sympathomimetic activity, high selectivity of β 1 receptor, or both α receptor blocking and vasodilating effects, such asBisoprolol, metoprolol and carvedilol.These drugs have little impact on metabolism and few adverse reactions, and can be safely used for hypertensive patients with diabetes, chronic obstructive pulmonary disease and peripheral vascular disease.
All patients with coronary heart disease should be treated with beta blockers for a long time as a secondary prevention.ST segment elevated myocardial infarction or non ST segment elevated myocardial infarctionAcute coronary syndromeIf patients cannot use it due to contraindications in the acute phase, they should be re evaluated before discharge, and beta blockers should be used as far as possible to improve the prognosis.
Application in heart failure
Beta blockers effectively antagonize the sympathetic nervous system, renin angiotensin aldosterone system and overactive nervesHumoral factor, plays an important role in blocking the vicious cycle chain of cardiovascular disease, thus delaying or reversingMyocardial remodeling, give play to improvementendogenousThe "biological effect" of myocardial function.
Application of β - blocker in arrhythmia β - blocker is the only antiarrhythmic drug that can reduce sudden cardiac death and total mortality.The application indications recommended as Class I include: partial sinus tachycardia, perioperative arrhythmia, atrial fibrillation with rapid ventricular response, ventricular tachycardia stormSympathetic excitationAnd some types of long QT syndrome.
Application in other cardiovascular diseases
1 Dilated cardiomyopathyIn the early stage, onlyCardiomegalyFor patients without clinical manifestations of heart failure, beta blockers can be used to reducemyocardial damage It is especially suitable for patients with fast heart rate, ventricular arrhythmia, and β receptor antibody positive.Patients with symptoms and signs of heart failure in the middle and late stages should be treated as chronic heart failure, and beta blockers should also be used.
2. Patients with hypertrophic cardiomyopathy with definite diagnosis, including those with early and mild symptoms, are suitable for beta blockers;The symptoms of patients with obstructive hypertrophic cardiomyopathy can be improved by using larger doses.
The combination of β - blocker andsodium nitroprusside, reduce blood flowaortaTo reduce the contraction rate of the left ventricle to slow down the progress of the disease.
6 LQTS
LQTS(geneticQT prolongation syndrome): Unless there are serious contraindications, beta blockers are the first choice for symptomatic LQTS patients today.If there is no absolute contraindication, lifelong use is recommendedMaximum tolerable doseβ - blocker can significantly reduce the occurrence of cardiovascular events.By 2015, it is believed that beta blockers are also recommended for asymptomatic LQTS patients.
7 Left atrioventricular valve prolapse
For patients with symptomatic left atrioventricular valve prolapse, beta blockers are usually the first choice.[1]
Common beta blockers
Announce
edit
(1)Atenolol(also known as aminoacyl propranolol), a cardiac selective beta blocker, has no endogenous inhibition of sympathetic nerve activity,half life6-9 hours, mostclinical research It shows that the blood pressure can be reduced continuously for 24 hours after taking the medicine once, especially forTachycardiamergehypertensionPatients.AndVasodilationAgentCalcium antagonistordiureticUsed together, the effect of reducing blood pressure is better.Someone is used to treat seriousHypertensive crisisAfter taking 10mg orally, the blood pressure gradually decreased within 12 hours, on averagesystolic pressure7.5kPa (56mmHg) drop,diastolic pressureIt is considered to be a safe and effective drug with a decrease of 5.3kPa (40mmHg).
(2)metoprolol(Trade nameBetaloc), is a selective beta receptor blocker.After it was introduced in 1975angina pectoris、myocardial infarction、ArrhythmiaAnd other aspects have achieved certain curative effects.In the treatment of hypertension, 100 mg was taken orally for 4 weeks, and the total effective rate was 82.4%. After 2 weeks of treatment, the blood pressure gradually decreased, but the heart rate did not decline, which could be significantly improvedHypertensive patientsOfdizzy、palpitation、vertigo、Chest tightnessIt is suitable for patients with primary and secondary hypertension.Its side effects include slow heart rate, fatigueXerostomia, chest tightness, etc., most of which can be relieved or disappeared after a period of treatment, but withbronchial asthmaorBradycardiaDisabled by.[2]
[Contraindication] This product is prohibited under the following circumstances: bronchial asthma,Sinus bradycardia, II or III degree atrioventricular block (unless there ispacemaker), congenital orAcquirabilityQ-T prolongation syndrome,Cardiogenic shock, uncontrolled heart failure andAllergic historyThe.
[Precautions] (1) Renal dysfunction may cause accumulation of this product, and the interval of medication should be extended according to creatinine clearance rate.(2) This product can pass through the placenta and secrete milk. Pregnant women and lactating women should use it with caution.(3) Same as other beta blockers.Do not stop taking medicine suddenly.(4) The following cases should be used with caution: heart failure controlled by digitalisHypokalemia, hypomagnesemia, first degree atrioventricular block.(5) Pay attention to monitoring during application: ① ECG, especiallyQ-T intervalChange; ②Blood pressure; ③electrolyte;④Renal function.
【Drug interaction】(1) When used together with other Class Ia, II and III antiarrhythmic drugsSynergy。(2) When used together with calcium antagonist, it can add barycenter conduction barrier to further inhibitventricular function , reduce blood pressure.(3) AndcatecholamineDrugs (such as reserpineGuanethidine)When used together, hypotension and severe bradycardia may occur.(4) There is an increase in blood sugar, which needs to be increasedinsulinandHypoglycemic drugsReport of.
【AdministrationNote] (1) When the QTc of ECG is greater than 500ms, attention should be paid to the proarrhythmic effect, and the drug should be stopped when the QTc exceeds 550ms.(2) If the drug needs to be stopped, it should be gradually reduced and used within 1 to 2 weeks.(3) When switching from other antiarrhythmic drugs to this product, this product should be stopped for 2~3 half lives of the previous drug under strict monitoring before use.fromamiodarone When replacing this product, it can be used only after Q-T returns to normal.
[Usage and dosage] (1) AdultCommon quantity: Oral administration starts from 80mg twice a day, and the dosage is increased to 120-160mg twice a day within 2-3 days according to the reaction.640mg per day.(2) Pediatric usage and safety: not yet determined.
[Pharmacology] (1) Pharmacodynamics: this product is non selectivecompetitivenessGround suppressionadrenalineβ receptor.The contraction force and contraction speed of the heart are reduced by weakening or preventing the excitation of beta receptorsconduction velocity Slows down, which weakens the heart's response to exercise or stress.Therefore, it can be used for the treatment of angina pectoris to reduce the heart muscleOxygen consumption, addExercise tolerance。Because of blockCardiac pacemakerPotential adrenaline can excite, so it is used to treat arrhythmia.This product may pass through the centralAdrenergic neuronBlocking and inhibitionreninIt can release blood and reduce cardiac output, and is suitable for treating hypertension.As this product can antagonize the catecholamine effect, it is also used to treat pheochromocytoma andHyperthyroidism, so that the activities of β 1 and β 2 receptors are both inSuppression state。
(2) Pharmacokinetics: after oral administrationGastrointestinal absorptionRelatively complete (90%), the blood drug concentration reaches the peak value in 1~1.5 hours, but before entering the systemic circulationImmediateIt is metabolized by the liverInactivationAnd the bioavailability is 30%.The binding rate with plasma protein was very high, 93%.t1/22-3 hours.throughRenal excretion, mainlyMetabolites, a small part (<1%) is the prototype.It cannot be discharged through dialysis.[Adverse reactions] (1) Dizziness or dizziness (caused by hypotension) and slow heart rate (<50 times/minute) are common.(2) Less common areBronchospasmAnd dyspneaCongestive heart failureMental confusion (especially in the elderly), mental depression,Unresponsive。(3) Less common arefeverandPharyngalgia(Agranulocytosis), rash(Anaphylactic reaction)、Bleeding tendency(Thrombocytopenia)。
(4) When adverse reactions persist, the following should be paid special attention:Raynaud diseaseLike cold limbs, diarrhea, fatigue, eyes, mouth orxerosis cutis, nausea, numbness of fingers and toes, abnormal fatigue, etc.
[Precautions] (1) This product can enter the fetus through the placenta. It is reported thatPregnancy hypertensionAfter use, it can be sent into the uterusFetal growth retardation, caused by weakness during deliverydystocia, newborn babies can produce hypotensionhypoglycemia、Respiratory depressionAlthough there are reports that it has no effect on the mother and fetus, it must be used with caution and should not be used as the first-line treatment drug for pregnant women.(2) It can secrete a small amount from milk, soLactating womenUse with caution.(3) The elderly have low capacity of metabolism and excretion of this product, so appropriate dosage should be taken.(4) Interference to diagnosis: when using this product, measure the bloodUrea nitrogen、Lipoprotein、creatinine, potassiumtriglyceride、uric acidAnd so on may increase;Blood sugar is reduced, butdiabetesPatients sometimes grow taller.Renal insufficiencyHourPropranololThe metabolites of can accumulate in the blood and interfere with the determination of serum bilirubinDiazo reaction, can appearfalse positive。(5) The following cases should be used with caution: ① allergy history; ②congestive heart failure;③Diabetes mellitus; ④emphysemaOr notAllergic bronchitis;⑤Hepatic insufficiency;⑥Hypothyroidism;⑦Raynaud's disease or othersPeripheral vascular disease;⑧Decreased renal function.(6) During the application of this productRegular inspectionroutine blood test, blood pressure, cardiac functionliver functionKidney function. Diabetic patients should check blood sugar regularly.(7) The dosage must be individualized. The dosage varies from person to person and from disease to disease. The dosage for patients with liver and kidney dysfunction is small;(8) Note that the blood concentration cannot be completely predictedPharmacological effect, so it should also be based on heart rate, blood pressure and other clinicalsignGuide clinical medication;(9)coronary heart diseasePatients should not stop suddenly when using this product, otherwise angina pectoris, myocardial infarction orVentricular tachycardia;(10)hyperthyroidismThe patient should not stop suddenly when using this product, otherwise it will aggravate the symptoms of hyperthyroidism;(11) Long term use can cause heart failure in a few patients. If it occurs, digitalis and (or) diuretics can be used to correct it.(12) Overtreatment: bradycardiaatropineorIsoproterenol, install if necessarypacemaker,Ventricular premature beattolidocaineorPhenytoin sodium。Heart failure oxygenation, digitalis orDiuretic。Infusion and administration in case of hypotensionPressor。Twitchdiazepam Or phenytoin sodium.Give isoproterenolaminophylline。
[Drug interaction] (1) andhypotensorInteraction: withclonidine If the drug needs to be stopped for the same use, stop using this product first, and then gradually reduce clonidine after a few days to avoid blood pressure fluctuation.AndMonoamine oxidase inhibitorIt can cause extreme hypotension when used together, so it is forbidden.AndreserpineUse the same. When the two effects are added together, the blocking effect of β receptor is enhanced, and bradycardia and hypotension may occur.(2) Same as digitalis glycoside.Atrial rate block may occur and lead to slow heart rate, so close observation is required.(3) Used with calcium antagonists, especially intravenouslyVerapamiWe should be very alert to the inhibition of myocardium and conduction system.(4) With adrenalinePhenylephrineOr sympathomimetic amines can cause significant hypertension, slow heart rate, and atrioventricular block, so close observation is required.(5) Can makeNon depolarizing muscle relaxantsasTubocurarine chloride、Galla ammonium iodideAnd so on.(6) This product can cause hypoglycemia in diabetic patients, so when used with hypoglycemic drugs, the dosage of the latter must be adjusted.(7) With isoproterenol orxanthineIf used together, the effect of the latter can be weakened.(8) AndchlorpromazineWhen used together, the blood drug concentration of both can be increased.(9) Phenytoin sodiumPhenobarbital、Li FupingAccelerate the removal of the product.(1O)Antipyrine, lidocainetheophyllineClass II slows the removal of the product.
[Description of administration] (1) Oral administration can be performed on an empty stomach or with food, which can slow the metabolism of the product in the liver and increase its bioavailability.(2) Long term users of this product should gradually reduce the dosage after at least 3 days, usually 2 weeks.Gradually decrease the product, and finally stop using it.
[Usage and dosage] (1) Angina pectoris, myocardial infarction: Take 10mg orally, 3-4 times a day, and increase 10~20mg every 3 days, and gradually increase to 200mg a day.(2) Hypertension: Take 10mg orally, 3-4 times a day, and gradually adjust it according to the needs and tolerance until the blood pressure is controlled.(3) Anti arrhythmias: oral, 10~30mg once, 3~4 times a day, dosage should be adjusted according to needs and tolerance.Severe arrhythmiaIn case of emergencyintravenous injection1~3mg, injected at a rate of no more than 1mg per minute, repeated once every 2 minutes if necessary, and once every 4 hours thereafter.(4)Hypertrophic cardiomyopathy: oral administration, 10-20mg once, 3-4 times a day, adjusted according to needs and tolerance.(5) Pheochromocytoma: oral administration, 10~20mg once, 3~4 times a day, 3 days before operation, often used with alpha receptor blocker, generally alpha receptor blocker should be used first, and this product should be added after the drug effect appears and becomes stable.(6)Sustained release tabletsTake 40mg early or late a day for the treatment of hypertension and angina pectoris.If necessary, it can be increased to 80mg.Prevention after myocardial infarction can be up to 160 mg per day.(7) The dosage for children has not yet been determined. Generally, it is taken orally at 0.5~1.0mg/kg per day, in batches;For intravenous injection, the weight shall be 0.0l~0.1mg/kg, and the amount shall not exceed lmg at a time.
[Indications] ①essential hypertension, used alone or in combination with other antihypertensive drugs such as diuretics. ②Symptomatic chronic congestive heart failure.
(2) Pharmacokinetics: The drug is easy to be absorbed after oral administration,First pass effectAbout 60%~75%.The bioavailability is 25%.When taken with food, absorption slows down, but there is no significant impact on bioavailability.In plasma andPlasma protein binding rate98%.This drug is completely metabolized,Metabolic half-lifeAbout 2 hours,metaboliteMain meridiansbileIt is excreted by feces, and about 16% is excreted by kidneys.This medicineLipophilicityHigh,Distribution volumeAbout 2L/kg, so it may be secreted with milk.Elimination half-lifeAbout 6~10 hoursHemodialysiseliminate.
[Contraindication] (1) People who are allergic to this product.(2) Pregnant and lactating women.(3) Low liver function.(4) Bronchospasm orasthma、Chronic obstructive pulmonary diseasepatient.(5) Severe bradycardia (heart rate<50 beats/minute)Sick sinus syndrome(including sinoatrial block), Ⅱ~Ⅲ degree atrioventricular block.(6) Cardiogenic shock.(7) Severe hypotension (systolic blood pressure<85mmHg).(8) Grade IV decompensated heart failure requires intravenousPositive muscle strengthPatients with drugs.
[Precautions] (1) Caution: ① Surgical patients. ②Hyperthyroidism. ③Patients with peripheral vascular diseases (such as intermittent claudication). ④Patients with pheochromocytoma ⑤Postural hypotension. ⑥Unstable orSecondary hypertensionPatients. ⑦Variant angina pectoris。⑧diabetic.(2) Impact of the drug on children: no patient under 18 years old has ever used this drug for safety and efficacyresearch data 。(3) Influence of drugs on test value or diagnosis: occasional serumAminotransferaseElevated, thrombocytopenia,Leukopenia。(4) This medicine may affect the ability to drive and operate the machine. It is more obvious at the beginning of medication, dose change or drinking.(5)anaesthesiaDuring this period, patients should closely observe the negativeMyodynamiaAnd hypotension.(6) Acceptdigoxin , diuretics, vascular tensionConverting enzymePatients treated with inhibitor drugs must first use these drugs to stabilize their condition, and then use carvedilol.(7) If it occurs during the use of this productTransitoryThe dosage of diuretics must be increased when heart failure is aggravated or water sodium retention occurs.Sometimes it is necessary to reduce or terminate the treatment of this drug.(8) Treatment of drug overdose: patients should adoptSupine position, keep observing and take measures when necessarySpecial caretreatment.Gastric lavage or drugs can be used to induce vomiting shortly after taking the drugs, and atropine 2mg can be injected intravenously for patients with excessive bradycardia.(9) Since the half-life of the drug is 7 to 10 hours, the detoxification treatment must last long enough in case of severe poisoning (shock symptoms).[1]
[Drug interaction] (1) This product can strengthen other antihypertensive drugs (such as:reserpine、Methyldopa、clonidine 、Calcium antagonist、Alpha receptorAntagonists, etc.) and drugs with side effects of lowering blood pressure(Barbiturate)、Phenothiazine, ErhuanantidepressantAnd the corresponding side effects are also increased.(2)Cimetidineetc.HepataseInhibitors can keep the drug in the bodyDecompositionIt may increase the blood concentration of the drug.(3) When this drug is used together with amiodarone, its effect on the heart is enhanced, and hypotension, bradycardia orCardiac arrest。(4) Heart block may occur when this drug is used together with diltiazem or verapamil.(5) This medicine may enhance the effect of insulin or oral hypoglycemic drugs.(6) This medicine andMethacholine acetateWhen used together, it can produce synergistic shrinkagea bronchial tubesmooth muscleFunction ofShrinkage timeExtension.(7) This medicine can inhibitCyclosporineThe metabolism of the latter increases the toxicity of the latter.(8) This medicine can increase the bioavailability andValley concentrationTo enhance its effect on the heart, cause atrioventricular block and toxic symptoms of digoxin. The clinical measurement of digoxin blood concentration should be strengthened.(9) Non steroidal anti-inflammatory drugs can reduce the antihypertensive effect of this drug.(10) RifampicinRiff puddingOther liver drug enzyme inducers can induce the metabolism of the drug, thus weakening the effect of the drug.(11) This medicine can blockadrenal glandβ effect of adrenergic acid, thus causing bradycardia and antagonizing the allergic reaction of adrenaline.(12) AndfentanylIn combination, it can produce severe hypotension. The mechanism is unknown.(13)MoxonidineMay occur when used in combination with this drugRebound hypertensionThe mechanism of action is still unclear.[2]
[Instruction for administration] (1) This drug generally needs to be used for a long time, and sudden drug withdrawal should be avoided. It should be gradually stopped for more than 1 to 2 weeks.It should be reduced as much as possible within 2-3 weeks after drug withdrawalphysical activityTo avoid worsening angina pectoris or other seriousCardiovascular disease。(2) When terminating the combined use of this drug and clonidine, this drug should be stopped first, and then the dosage of clonidine should be gradually reduced after a few days.(3) Before taking carvedilol, patients with pheochromocytoma should first use alpha receptor blocker.(4) Carvedilol must be reduced for bradycardia with heart rate<55 beats/minute.(5) Although the time of taking this medicine has nothing to do with meals, it must be taken with meals for patients with congestive heart failure to slow absorption and reduce the occurrence of postural hypotension.
【Usage and dosage】(1) Common dosage for adults: oral, ① essential hypertension andangina pectoris, the initial dose is 12.5 mg, once a day, oral;Take 25mg orally once a day after two days, and then gradually increase the dosage to 50mg a day as required, taking it 1-2 times. ②For chronic congestive heart failure, the dose must be individualized, and close observation is required to increase the dose.The recommended dose is 3.125mg twice a day for the first two weeks. If well tolerated, the dose can be increased to 6.25mg twice a day after an interval of at least two weeks, then 12.5mg twice a day, then 25mg twice a day.The dose must be increased to the maximum level that the patient can tolerate.For those whose weight is less than 85 kg, the maximum recommended dose is 25 mg, twice a day;For those whose weight is>85 kg, the maximum recommended dose is 50 mg, twice a day.When carvedilol is stopped for more than 2 weeks, it should be reapplied with 3.125mg once, twice a day, and then the dosage should be increased according to the above recommended method.(2) Dose for the elderly: the initial dose for patients with primary hypertension is 12.5 mg once a day.If the effect is not good, the dose can be increased to the recommended maximum dose of 50mg a day after an interval of at least 2 weeks, once a day or in batches.